Sonova Holding Ltd.

SOON

Equity

ISIN CH0012549785 / Valor 1254978

SIX Swiss Exchange (2025-11-21)

CHF 194.90+0.52%

Sonova Holding Ltd.
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Sonova Holding Ltd., founded in 1947 and headquartered in Stäfa, Switzerland, is a prominent global provider of hearing care solutions. The company operates through four main business segments: Hearing Instruments, Audiological Care, Consumer Hearing, and Cochlear Implants. Sonova's product portfolio includes personal audio devices, wireless communication systems, hearing aids, and cochlear implants, catering to a diverse range of hearing needs. The company markets its products under several core brands, including Phonak, Unitron, AudioNova, and Advanced Bionics, and holds a license for the Sennheiser brand. With a robust global presence, Sonova serves customers in over 100 countries through a well-established network of sales and distribution channels.

Summarized from source with an LLMView SourceSector: Healthcare

Sales and EBITA Growth

For the financial year 2024/25, Sonova Holding Ltd. reported group sales of CHF 3,865.4 million, marking a 7.6% increase in local currencies and a 6.6% rise in Swiss francs. Adjusted Group EBITA reached CHF 807.8 million, up by 7.4% in local currencies and 4.7% in Swiss francs, reflecting strong operational performance despite unfavorable exchange rates.

Successful Product Launches Drive Expansion

The company’s growth was propelled by the successful launch of the Phonak Infinio and Sphere Infinio platforms, which significantly boosted the Hearing Instruments and Audiological Care businesses. These new products were well-received in the market, leading to substantial market share gains and accelerating sales growth in the second half of the financial year.

Regional Performance Highlights

Sonova demonstrated solid performance across all regions. Sales in EMEA increased by 7.0% in local currencies, while the United States saw a 7.7% rise, supported by above-market growth in Hearing Instruments. The Asia Pacific region experienced an 8.1% growth, driven by strong performance in Australia and significant growth in China’s Cochlear Implants and Consumer Hearing sectors.

CEO Transition and Leadership Change

Sonova announced that Arnd Kaldowski will step down as CEO effective September 30, 2025, due to personal reasons. Eric Bernard, former CEO of WS Audiology, will join Sonova on July 1, 2025, taking over full responsibilities as CEO by October 1, 2025. This planned transition aims to support the company’s continued growth and strategic objectives.

Dividend Proposal and Future Outlook

The Board of Directors proposed a dividend of CHF 4.40 per share to the Annual General Shareholders’ Meeting. Looking ahead to the 2025/26 financial year, Sonova expects consolidated sales to grow by 5-9% and EBITA to increase by 14-18%, after restructuring costs and excluding special items, both measured at constant exchange rates.

Summarized from source with an LLMView Source

Key figures

-35.9%1Y

-21.1%3Y

-13.1%5Y

Performance

21.2%1Y

24.9%3Y

29.1%5Y

Volatility